Jan Eriksson - Publications

Affiliations: 
Neuroheuristic Research Group 

166 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Torres AN, Tavares L, Pereira MJ, Eriksson JW, Jones JG. Positional and compositional analysis of saturated, monounsaturated, and polyunsaturated fatty acids in human adipose tissue triglyceride by C nuclear magnetic resonance. Nmr in Biomedicine. e4632. PMID 34676601 DOI: 10.1002/nbm.4632  1
2021 Sarsenbayeva A, Jui BN, Fanni G, Barbosa P, Ahmed F, Kristófi R, Cen J, Chowdhury A, Skrtic S, Bergsten P, Fall T, Eriksson JW, Pereira MJ. Impaired HMG-CoA Reductase Activity Caused by Genetic Variants or Statin Exposure: Impact on Human Adipose Tissue, β-Cells and Metabolome. Metabolites. 11. PMID 34564389 DOI: 10.3390/metabo11090574  1
2021 Kristófi R, Eriksson JW. Metformin as an anti-inflammatory agent: a short review. The Journal of Endocrinology. PMID 34463292 DOI: 10.1530/JOE-21-0194  1
2021 Sundström J, Kristófi R, Östlund O, Bennet L, Eliasson B, Jansson S, Leksell J, Almby K, Lundqvist M, Eriksson JW. A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol. Journal of Diabetes and Its Complications. 107996. PMID 34389234 DOI: 10.1016/j.jdiacomp.2021.107996  1
2021 Röhnisch HE, Eriksson J, Tran LV, Müllner E, Sandström C, Moazzami AA. Improved Automated Quantification Algorithm (AQuA) and Its Application to NMR-Based Metabolomics of EDTA-Containing Plasma. Analytical Chemistry. PMID 34128648 DOI: 10.1021/acs.analchem.0c04233  1
2021 Almby KE, Katsogiannos P, Pereira MJ, Karlsson FA, Sundbom M, Wiklund U, Kamble PG, Eriksson JW. Time course of metabolic, neuroendocrine and adipose effects during 2 years of follow-up after RYGB in patients with T2D. The Journal of Clinical Endocrinology and Metabolism. PMID 34086911 DOI: 10.1210/clinem/dgab398  1
2021 Eriksson JW, Visvanathar R, Kullberg J, Strand R, Skrtic S, Ekström S, Lubberink M, Lundqvist MH, Katsogiannos P, Pereira MJ, Ahlström H. Tissue-specific glucose partitioning and fat content in prediabetes and type 2 diabetes: Whole-body PET/MRI during hyperinsulinemia. European Journal of Endocrinology. PMID 33852422 DOI: 10.1530/EJE-20-1359  1
2021 Almby KE, Lundqvist MH, Abrahamsson N, Kvernby S, Fahlström M, Pereira MJ, Gingnell M, Karlsson FA, Fanni G, Sundbom M, Wiklund U, Haller S, Lubberink M, Wikström J, Eriksson JW. Effects of Gastric Bypass Surgery on the Brain; Simultaneous Assessment of Glucose Uptake, Blood Flow, Neural Activity and Cognitive Function during Normo- and Hypoglycemia. Diabetes. PMID 33674408 DOI: 10.2337/db20-1172  1
2021 Kristófi R, Bodegard J, Norhammar A, Thuresson M, Nathanson D, Nyström T, Birkeland KI, Eriksson JW. Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study. Diabetes Care. PMID 33653822 DOI: 10.2337/dc20-2839  1
2021 Tietjen AK, Ghandour R, Mikki N, Jerdén L, Eriksson JW, Norberg M, Husseini A. Quality of life of type 2 diabetes mellitus patients in Ramallah and al-Bireh Governorate-Palestine: a part of the Palestinian diabetes complications and control study (PDCCS). Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 33651277 DOI: 10.1007/s11136-020-02733-w  1
2021 Katsogiannos P, Kamble PG, Pereira MJ, Sundbom M, Carlsson PO, Eriksson JW, Espes D. Changes in Circulating Cytokines and Adipokines After RYGB in Patients with and without Type 2 Diabetes. Obesity (Silver Spring, Md.). 29: 535-542. PMID 33624436 DOI: 10.1002/oby.23093  1
2020 Sarsenbayeva A, Dipta P, Lundqvist M, Almby KE, Tirosh B, Di Nunzio G, Eriksson JW, Pereira MJ. Human macrophages stimulate expression of inflammatory mediators in adipocytes; effects of second-generation antipsychotics and glucocorticoids on cellular cross-talk. Psychoneuroendocrinology. 125: 105071. PMID 33360972 DOI: 10.1016/j.psyneuen.2020.105071  1
2020 Lundqvist MH, Almby K, Wiklund U, Abrahamsson N, Kamble PG, Pereira MJ, Eriksson JW. Altered hormonal and autonomic nerve responses to hypo- and hyperglycaemia are found in overweight and insulin-resistant individuals and may contribute to the development of type 2 diabetes. Diabetologia. PMID 33241460 DOI: 10.1007/s00125-020-05332-z  1
2020 Lind L, Salihovic S, Risérus U, Kullberg J, Johansson L, Ahlström H, Eriksson JW, Oscarsson J. The Plasma Metabolomic Profile is Differently Associated with Liver Fat, Visceral Adipose Tissue, and Pancreatic Fat. The Journal of Clinical Endocrinology and Metabolism. PMID 33123723 DOI: 10.1210/clinem/dgaa693  1
2020 Katsogiannos P, Randell E, Sundbom M, Rosenblad A, Eriksson JW, Leksell J. Quality of life after gastric bypass surgery in patients with type 2 diabetes: patients' experiences during 2 years of follow-up. Diabetology & Metabolic Syndrome. 12: 90. PMID 33062061 DOI: 10.1186/s13098-020-00597-1  1
2020 Birkeland KI, Bodegard J, Banerjee A, Kim DJ, Norhammar A, Eriksson JW, Thuresson M, Okami S, Ha KH, Kossack N, Mamza JB, Zhang R, Yajima T, Komuro I, Kadowaki T. Lower Cardiorenal Risk with Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Patients without Cardiovascular and Renal Diseases: A large multinational observational study. Diabetes, Obesity & Metabolism. PMID 32893440 DOI: 10.1111/dom.14189  1
2020 Lind L, Johansson L, Ahlström H, Eriksson JW, Larsson A, Risérus U, Kullberg J, Oscarsson J. Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population. World Journal of Hepatology. 12: 149-159. PMID 32685107 DOI: 10.4254/wjh.v12.i4.149  1
2020 Kamble PG, Hetty S, Vranic M, Almby K, Castillejo-López C, Abalo XM, Pereira MJ, Eriksson JW. Proof-of-concept for CRISPR/Cas9 gene editing in human preadipocytes: Deletion of FKBP5 and PPARG and effects on adipocyte differentiation and metabolism. Scientific Reports. 10: 10565. PMID 32601291 DOI: 10.1038/s41598-020-67293-y  1
2020 Kamble PG, Theorell-Haglöw J, Wiklund U, Franklin KA, Hammar U, Lindberg E, Eriksson JW. Sleep apnea in men is associated with altered lipid metabolism, glucose tolerance, insulin sensitivity, and body fat percentage. Endocrine. PMID 32562183 DOI: 10.1007/s12020-020-02369-3  1
2020 Sjöholm Å, Pereira MJ, Nilsson T, Linde T, Katsogiannos P, Saaf J, Eriksson JW. Type B insulin resistance syndrome in a patient with type 1 diabetes. Endocrinology, Diabetes & Metabolism Case Reports. 2020. PMID 32478674 DOI: 10.1530/EDM-19-0157  1
2020 Diamanti K, Visvanathar R, Pereira MJ, Cavalli M, Pan G, Kumar C, Skrtic S, Risérus U, Eriksson JW, Kullberg J, Komorowski J, Wadelius C, Ahlström H. Integration of whole-body [F]FDG PET/MRI with non-targeted metabolomics can provide new insights on tissue-specific insulin resistance in type 2 diabetes. Scientific Reports. 10: 8343. PMID 32433479 DOI: 10.1038/s41598-020-64524-0  1
2020 Birkeland KI, Bodegard J, Eriksson JW, Norhammar A, Haller H, Linssen GCM, Banerjee A, Thuresson M, Okami S, Garal-Pantaler E, Overbeek J, Mamza JB, Zhang R, Yajima T, Komuro I, et al. Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: a large multinational cohort study. Diabetes, Obesity & Metabolism. PMID 32363737 DOI: 10.1111/dom.14074  1
2020 Mulder S, Hammarstedt A, Nagaraj SB, Nair V, Ju W, Hedberg J, Greasley PJ, Eriksson JW, Oscarsson J, Heerspink HJL. A metabolomics based molecular pathway analysis for how the SGLT2-inhibitor dapagliflozin may slow kidney function decline in patients with diabetes. Diabetes, Obesity & Metabolism. PMID 32115853 DOI: 10.1111/dom.14018  1
2020 Katsogiannos P, Kamble PG, Wiklund U, Sundbom M, Espes D, Hammar U, Karlsson FA, Pereira MJ, Eriksson JW. Rapid changes in neuroendocrine regulation may contribute to reversal of type 2 diabetes after gastric bypass surgery. Endocrine. PMID 31983031 DOI: 10.1007/s12020-020-02203-w  1
2020 Adler K, Piikki K, Söderström M, Eriksson J, Alshihabi O. Predictions of Cu, Zn, and Cd Concentrations in Soil Using Portable X-Ray Fluorescence Measurements. Sensors (Basel, Switzerland). 20. PMID 31947672 DOI: 10.3390/s20020474  1
2019 Pereira MJ, Thombare K, Sarsenbayeva A, Kamble PG, Almby K, Lundqvist M, Eriksson JW. Direct effects of glucagon on glucose uptake and lipolysis in human adipocytes. Molecular and Cellular Endocrinology. 110696. PMID 31891768 DOI: 10.1016/j.mce.2019.110696  1
2019 Diamanti K, Cavalli M, Pan G, Pereira MJ, Kumar C, Skrtic S, Grabherr M, Risérus U, Eriksson JW, Komorowski J, Wadelius C. Author Correction: Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes. Scientific Reports. 9: 18158. PMID 31776441 DOI: 10.1038/s41598-019-54423-4  1
2019 Granstam E, Rosenblad A, Modher Raghib A, Granström T, Eriksson JW, Lindholm Olinder A, Leksell J. Long-term follow-up of antivascular endothelial growth factor treatment for diabetic macular oedema: a four-year real-world study. Acta Ophthalmologica. PMID 31656056 DOI: 10.1111/aos.14290  1
2019 Sarsenbayeva A, Marques-Santos CM, Thombare K, Di Nunzio G, Almby KE, Lundqvist M, Eriksson JW, Pereira MJ. Effects of second-generation antipsychotics on human subcutaneous adipose tissue metabolism. Psychoneuroendocrinology. 110: 104445. PMID 31563732 DOI: 10.1016/j.psyneuen.2019.104445  1
2019 Edén D, Panagiotou G, Mokhtari D, Eriksson JW, Åberg M, Siegbahn A. Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner. Upsala Journal of Medical Sciences. 1-10. PMID 31407948 DOI: 10.1080/03009734.2019.1645248  0.01
2019 Norhammar A, Bodegard J, Nyström T, Thuresson M, Rikner K, Nathanson D, Eriksson JW. Dapagliflozin vs Non-SGLT-2i Treatment is Associated with Lower Hospital Care Costs in Type 2 Diabetes Patients Similar to the DECLARE-TIMI 58 Participants: A Nationwide Observational Study. Diabetes, Obesity & Metabolism. PMID 31379124 DOI: 10.1111/dom.13852  1
2019 Diamanti K, Cavalli M, Pan G, Pereira MJ, Kumar C, Skrtic S, Grabherr M, Risérus U, Eriksson JW, Komorowski J, Wadelius C. Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes. Scientific Reports. 9: 9653. PMID 31273253 DOI: 10.1038/s41598-019-45906-5  1
2019 Mosenzon O, Blicher TM, Rosenlund S, Eriksson JW, Heller S, Hels OH, Pratley R, Sathyapalan T, Desouza C. Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial. The Lancet. Diabetes & Endocrinology. PMID 31189517 DOI: 10.1016/S2213-8587(19)30192-5  0.01
2019 Almby KE, Abrahamsson N, Lundqvist MH, Hammar U, Thombare K, Panagiotou A, Karlsson FA, Sundbom M, Wiklund U, Eriksson J. Effects of GLP-1 on counter-regulatory responses during hypoglycemia after GBP surgery. European Journal of Endocrinology. PMID 31176298 DOI: 10.1530/EJE-19-0171  1
2019 Lundqvist MH, Almby K, Abrahamsson N, Eriksson JW. Is the Brain a Key Player in Glucose Regulation and Development of Type 2 Diabetes? Frontiers in Physiology. 10: 457. PMID 31133864 DOI: 10.3389/fphys.2019.00457  1
2019 Kamble PG, Pereira MJ, Almby K, Eriksson JW. Estrogen interacts with glucocorticoids in the regulation of lipocalin 2 expression in human adipose tissue. Reciprocal roles of estrogen receptor α and β in insulin resistance? Molecular and Cellular Endocrinology. PMID 30953748 DOI: 10.1016/j.mce.2019.04.002  1
2019 Pereira MJ, Eriksson JW. Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity. Drugs. PMID 30701480 DOI: 10.1007/s40265-019-1057-0  1
2019 Katsogiannos P, Kamble PG, Boersma GJ, Karlsson FA, Lundkvist P, Sundbom M, Pereira MJ, Eriksson JW. Early changes in adipose tissue morphology, gene expression and metabolism after RYGB in patients with obesity and T2D. The Journal of Clinical Endocrinology and Metabolism. PMID 30689903 DOI: 10.1210/Jc.2018-02165  1
2019 Östman JR, Müllner E, Eriksson J, Kristinsson H, Gustafsson J, Witthöft C, Bergsten P, Moazzami AA. Glucose Appearance Rate Rather than the Blood Glucose Concentrations Explain Differences in Postprandial Insulin Responses between Wholemeal Rye and Refined Wheat Breads - Results from A Cross-Over Meal Study. Molecular Nutrition & Food Research. e1800959. PMID 30636184 DOI: 10.1002/mnfr.201800959  1
2019 Norhammar A, Bodegard J, Nyström T, Thuresson M, Nathanson D, Eriksson JW. Dapagliflozin and Cardiovascular Mortality and Disease Outcomes in Type 2 Diabetes Patients Similar to the DECLARE-TIMI 58 Participants: A Nationwide Observational Study. Diabetes, Obesity & Metabolism. PMID 30609272 DOI: 10.1111/dom.13627  1
2018 Persson F, Bodegard J, Lahtela JT, Nyström T, Jørgensen ME, Jensen ML, Gulseth HL, Thuresson M, Hoti F, Nathanson D, Norhammar A, Birkeland KI, Eriksson JG, Eriksson JW. Different patterns of second-line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study. Endocrinology, Diabetes & Metabolism. 1: e00036. PMID 30815564 DOI: 10.1002/edm2.36  1
2018 Boersma GJ, Johansson E, Pereira MJ, Heurling K, Skrtic S, Lau J, Katsogiannos P, Panagiotou G, Lubberink M, Kullberg J, Ahlström H, Eriksson JW. Altered Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Predict Whole-Body Insulin Resistance and may Contribute to the Development of Type 2 Diabetes: A Combined PET/MR Study. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme. 50: e10. PMID 30669164 DOI: 10.1055/a-0831-3620  1
2018 Oscarsson J, Önnerhag K, Risérus U, Sundén M, Johansson L, Jansson PA, Moris L, Nilsson PM, Eriksson JW, Lind L. Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study. Journal of Clinical Lipidology. PMID 30197273 DOI: 10.1016/j.jacl.2018.08.003  1
2018 Lundkvist P, Pereira MJ, Kamble PG, Katsogiannos P, Langkilde AM, Esterline R, Johnsson E, Eriksson JW. Glucagon Levels during Short-term SGLT2 Inhibition are Largely Regulated by Glucose Changes in Type 2 Diabetes Patients. The Journal of Clinical Endocrinology and Metabolism. PMID 30137410 DOI: 10.1210/jc.2018-00969  1
2018 Hadrévi J, Jonsdottir IH, Jansson PA, Eriksson JW, Sjörs A. Plasma metabolomic patterns in patients with exhaustion disorder. Stress (Amsterdam, Netherlands). 1-10. PMID 30084722 DOI: 10.1080/10253890.2018.1494150  1
2018 Ghandour R, Mikki N, Abu Rmeileh NME, Jerdén L, Norberg M, Eriksson JW, Husseini A. Complications of type 2 diabetes mellitus in Ramallah and al-Bireh: The Palestinian Diabetes Complications and Control Study (PDCCS). Primary Care Diabetes. PMID 30072279 DOI: 10.1016/j.pcd.2018.07.002  1
2018 Kamble PG, Pereira MJ, Gustafsson S, Lundkvist P, Castillejo-López C, Fall T, Ingelsson E, Eriksson JW. Role of peroxisome proliferator-activated receptor gamma Pro12Ala polymorphism in human adipose tissue: assessment of adipogenesis and adipocyte glucose and lipid turnover. Adipocyte. PMID 30064293 DOI: 10.1080/21623945.2018.1503030  1
2018 Sidibeh CO, Pereira MJ, Abalo XM, J Boersma G, Skrtic S, Lundkvist P, Katsogiannos P, Hausch F, Castillejo-López C, Eriksson JW. FKBP5 expression in human adipose tissue: potential role in glucose and lipid metabolism, adipogenesis and type 2 diabetes. Endocrine. PMID 30032404 DOI: 10.1007/S12020-018-1674-5  1
2018 Boersma GJ, Johansson E, Pereira MJ, Heurling K, Skrtic S, Lau J, Katsogiannos P, Panagiotou G, Lubberink M, Kullberg J, Ahlström H, Eriksson JW. Altered Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Predict Whole-Body Insulin Resistance and may Contribute to the Development of Type 2 Diabetes: A Combined PET/MR Study. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme. PMID 30001566 DOI: 10.1055/A-0643-4739  1
2018 Eriksson JW, Lundkvist P, Jansson PA, Johansson L, Kvarnström M, Moris L, Miliotis T, Forsberg GB, Risérus U, Lind L, Oscarsson J. Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study. Diabetologia. PMID 29971527 DOI: 10.1007/s00125-018-4675-2  1
2018 Pereira MJ, Lundkvist P, Kamble PG, Lau J, Martins JG, Sjöström CD, Schnecke V, Walentinsson A, Johnsson E, Eriksson JW. A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders. PMID 29949016 DOI: 10.1007/s13300-018-0449-6  1
2018 Nyström T, Bodegård J, Nathanson D, Thuresson M, Norhammar A, Eriksson JW. Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10. Diabetes Care. 41: e104-e105. PMID 29784707 DOI: 10.2337/dc18-0339  1
2018 Hansson SF, Zhou AX, Vachet P, Eriksson JW, Pereira MJ, Skrtic S, Jongsma Wallin H, Ericsson-Dahlstrand A, Karlsson D, Ahnmark A, Sörhede Winzell M, Magnone MC, Davidsson P. Secretagogin is increased in plasma from type 2 diabetes patients and potentially reflects stress and islet dysfunction. Plos One. 13: e0196601. PMID 29702679 DOI: 10.1371/journal.pone.0196601  1
2018 Fonseca ACRG, Carvalho E, Eriksson JW, Pereira MJ. Calcineurin is an important factor involved in glucose uptake in human adipocytes. Molecular and Cellular Biochemistry. PMID 29380240 DOI: 10.1007/s11010-017-3261-0  1
2018 Kamble PG, Gustafsson S, Pereira MJ, Lundkvist P, Cook N, Lind L, Franks PW, Fall T, Eriksson JW, Ingelsson E. Genotype-based recall to study metabolic effects of genetic variation: a pilot study of PPARG Pro12Ala carriers. Upsala Journal of Medical Sciences. 1-9. PMID 29303622 DOI: 10.1080/03009734.2017.1405127  1
2017 Nathanson D, Sabale U, Eriksson JW, Nyström T, Norhammar A, Olsson U, Bodegård J. Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006-2014. Pharmacoeconomics - Open. PMID 29623637 DOI: 10.1007/s41669-017-0063-y  1
2017 Lind L, Önnerhag K, Riserus U, Kvarnström M, Johansson L, Jansson PA, Moris L, Nilsson P, Eriksson JW, Oscarsson J. Effects of free omega-3 carboxylic acids and fenofibrate on liver steatosis and serum lipoproteins in overweight patients with hypertriglyceridemia and non-alcoholic fatty liver disease (NAFLD). Atherosclerosis. 263: e260. PMID 29365992 DOI: 10.1016/j.atherosclerosis.2017.06.842  1
2017 Röhnisch HE, Eriksson J, Müllner E, Agback P, Sandström C, Moazzami AA. AQuA - an automated quantification algorithm for high-throughput NMR-based metabolomics and its application in human plasma. Analytical Chemistry. PMID 29260864 DOI: 10.1021/acs.analchem.7b04324  1
2017 Marklund M, Pingel R, Rosqvist F, Lindroos AK, Eriksson JW, Vessby B, Oscarsson J, Lind L, Risérus U. Fatty Acid Proportions in Plasma Cholesterol Esters and Phospholipids Are Positively Correlated in Various Swedish Populations. The Journal of Nutrition. PMID 28931585 DOI: 10.3945/jn.117.254250  1
2017 Johansson E, Lubberink M, Heurling K, Eriksson JW, Skrtic S, Ahlström H, Kullberg J. Whole-Body Imaging of Tissue-specific Insulin Sensitivity and Body Composition by Using an Integrated PET/MR System: A Feasibility Study. Radiology. 162949. PMID 28846496 DOI: 10.1148/radiol.2017162949  1
2017 Birkeland KI, Jørgensen ME, Carstensen B, Persson F, Gulseth HL, Thuresson M, Fenici P, Nathanson D, Nyström T, Eriksson JW, Bodegård J, Norhammar A. Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis. The Lancet. Diabetes & Endocrinology. PMID 28781064 DOI: 10.1016/S2213-8587(17)30258-9  1
2017 Persson F, Nyström T, Jørgensen ME, Carstensen B, Gulseth HL, Thuresson M, Fenici P, Nathanson D, Eriksson JW, Norhammar A, Bodegard J, Birkeland KI. Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study. Diabetes, Obesity & Metabolism. PMID 28771923 DOI: 10.1111/dom.13077  1
2017 Lundkvist P, Pereira MJ, Katsogiannos P, Sjöström CD, Johnsson E, Eriksson JW. Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: sustained reductions in bodyweight, glycaemia, and blood pressure over 1 year. Diabetes, Obesity & Metabolism. PMID 28345814 DOI: 10.1111/dom.12954  1
2017 Nyström T, Bodegard J, Nathanson D, Thuresson M, Norhammar A, Eriksson JW. Novel oral glucose-lowering drugs compared to insulin are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycemia in type 2 diabetes patients. Diabetes, Obesity & Metabolism. PMID 28116795 DOI: 10.1111/dom.12889  1
2016 Nyström T, Bodegard J, Nathanson D, Thuresson M, Norhammar A, Eriksson JW. Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemia. Diabetes Research and Clinical Practice. 123: 199-208. PMID 28056431 DOI: 10.1016/j.diabres.2016.12.004  1
2016 Piikki K, Söderström M, Eriksson J, Muturi John J, Ireri Muthee P, Wetterlind J, Lund E. Performance Evaluation of Proximal Sensors for Soil Assessment in Smallholder Farms in Embu County, Kenya. Sensors (Basel, Switzerland). 16. PMID 27869774 DOI: 10.3390/s16111950  1
2016 Sidibeh CO, Pereira MJ, Lau Börjesson J, Kamble PG, Skrtic S, Katsogiannos P, Sundbom M, Svensson MK, Eriksson JW. Role of cannabinoid receptor 1 in human adipose tissue for lipolysis regulation and insulin resistance. Endocrine. PMID 27858284 DOI: 10.1007/s12020-016-1172-6  1
2016 Pereira MJ, Skrtic S, Katsogiannos P, Abrahamsson N, Sidibeh CO, Dahgam S, Månsson M, Risérus U, Kullberg J, Eriksson JW. Impaired adipose tissue lipid storage, but not altered lipolysis, contributes to elevated levels of NEFA in type 2 diabetes. Degree of hyperglycemia and adiposity are important factors. Metabolism: Clinical and Experimental. 65: 1768-1780. PMID 27832864 DOI: 10.1016/j.metabol.2016.09.008  1
2016 Granström T, Forsman H, Lindholm Olinder A, Gkretsis D, Eriksson JW, Granstam E, Leksell J. Patient-reported outcomes and visual acuity after 12months of anti-VEGF-treatment for sight-threatening diabetic macular edema in a real world setting. Diabetes Research and Clinical Practice. 121: 157-165. PMID 27718374 DOI: 10.1016/j.diabres.2016.09.015  1
2016 Lundkvist P, David Sjöström C, Amini S, Pereira MJ, Johnsson E, Eriksson JW. Dapagliflozin QD and exenatide QW dual therapy: a 24-week randomized, placebo-controlled, phase 2 study examining effects on bodyweight and prediabetes in obese nondiabetic adults. Diabetes, Obesity & Metabolism. PMID 27550386 DOI: 10.1111/dom.12779  1
2016 Svensson MK, Lindmark S, Wiklund U, Rask P, Karlsson M, Myrin J, Kullberg J, Johansson L, Eriksson JW. Alterations in heart rate variability during everyday life are linked to insulin resistance. A role of dominating sympathetic over parasympathetic nerve activity? Cardiovascular Diabetology. 15: 91. PMID 27352833 DOI: 10.1186/s12933-016-0411-8  1
2016 Eriksson JW, Bodegard J, Nathanson D, Thuresson M, Nyström T, Norhammar A. Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality. Diabetes Research and Clinical Practice. 117: 39-47. PMID 27329021 DOI: 10.1016/j.diabres.2016.04.055  1
2016 Abrahamsson N, Börjesson JL, Sundbom M, Wiklund U, Karlsson FA, Eriksson JW. Gastric Bypass Reduces Symptoms and Hormonal Responses in Hypoglycemia. Diabetes. 65: 2667-75. PMID 27313315 DOI: 10.2337/db16-0341  1
2016 Fryk E, Sundelin JP, Strindberg L, Pereira MJ, Federici M, Marx N, Nyström FH, Schmelz M, Svensson PA, Eriksson JW, Borén J, Jansson PA. Microdialysis and proteomics of subcutaneous interstitial fluid reveals increased galectin-1 in type 2 diabetes patients. Metabolism: Clinical and Experimental. 65: 998-1006. PMID 27282870 DOI: 10.1016/j.metabol.2016.04.003  1
2016 Norhammar A, Bodegård J, Nyström T, Thuresson M, Eriksson JW, Nathanson D. Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006-2013. Diabetologia. 59: 1692-701. PMID 27189067 DOI: 10.1007/s00125-016-3971-y  1
2016 Dahlin AS, Eriksson J, Campbell CD, Öborn I. Soil amendment affects Cd uptake by wheat - are we underestimating the risks from chloride inputs? The Science of the Total Environment. 554: 349-357. PMID 26974588 DOI: 10.1016/j.scitotenv.2016.02.049  1
2016 Kamble PG, Pereira MJ, Sidibeh CO, Amini S, Sundbom M, Börjesson JL, Eriksson JW. Lipocalin 2 produces insulin resistance and can be upregulated by glucocorticoids in human adipose tissue. Molecular and Cellular Endocrinology. 427: 124-32. PMID 26973291 DOI: 10.1016/j.mce.2016.03.011  1
2016 Rautio A, Boman K, Eriksson JW, Svensson MK. Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up. Diabetes & Vascular Disease Research. 13: 183-91. PMID 26818227 DOI: 10.1177/1479164115618516  1
2015 Lindholm-Olinder A, Fischier J, Fries J, Alfonsson S, Elvingson V, Eriksson JW, Leksell J. A randomised wait-list controlled clinical trial of the effects of acceptance and commitment therapy in patients with type 1 diabetes: a study protocol. Bmc Nursing. 14: 61. PMID 26594131 DOI: 10.1186/s12912-015-0101-y  1
2015 Taube M, Andersson-Assarsson JC, Lindberg K, Pereira MJ, Gäbel M, Svensson MK, Eriksson JW, Svensson PA. Evaluation of reference genes for gene expression studies in human brown adipose tissue. Adipocyte. 4: 280-5. PMID 26451284 DOI: 10.1080/21623945.2015.1039884  1
2014 Liu L, Trent CM, Fang X, Son NH, Jiang H, Blaner WS, Hu Y, Yin YX, Farese RV, Homma S, Turnbull AV, Eriksson JW, Hu SL, Ginsberg HN, Huang LS, et al. Cardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure. The Journal of Biological Chemistry. 289: 29881-91. PMID 25157099 DOI: 10.1074/jbc.M114.601864  1
2014 Bengtsson SB, Gärdenäs AI, Eriksson J, Vinichuk M, Rosén K. Interception and retention of wet-deposited radiocaesium and radiostrontium on a ley mixture of grass and clover. The Science of the Total Environment. 497: 412-9. PMID 25146910 DOI: 10.1016/j.scitotenv.2014.07.099  1
2014 Kumpiene J, Bert V, Dimitriou I, Eriksson J, Friesl-Hanl W, Galazka R, Herzig R, Janssen J, Kidd P, Mench M, Müller I, Neu S, Oustriere N, Puschenreiter M, Renella G, et al. Selecting chemical and ecotoxicological test batteries for risk assessment of trace element-contaminated soils (phyto)managed by gentle remediation options (GRO). The Science of the Total Environment. 496: 510-22. PMID 25108253 DOI: 10.1016/j.scitotenv.2014.06.130  1
2014 Pereira MJ, Palming J, Rizell M, Aureliano M, Carvalho E, Svensson MK, Eriksson JW. Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents. The Journal of Clinical Endocrinology and Metabolism. 99: E1885-94. PMID 25004245 DOI: 10.1210/jc.2014-1266  1
2014 Pereira MJ, Palming J, Svensson MK, Rizell M, Dalenbäck J, Hammar M, Fall T, Sidibeh CO, Svensson PA, Eriksson JW. FKBP5 expression in human adipose tissue increases following dexamethasone exposure and is associated with insulin resistance. Metabolism: Clinical and Experimental. 63: 1198-208. PMID 24997500 DOI: 10.1016/j.metabol.2014.05.015  1
2014 Eriksson O, Espes D, Selvaraju RK, Jansson E, Antoni G, Sorensen J, Lubberink M, Biglarnia AR, Eriksson JW, Sundin A, Ahlström H, Eriksson B, Johansson L, Carlsson PO, Korsgren O. Positron emission tomography ligand [11C]5-hydroxy- Tryptophan can be used as a surrogate marker for the human endocrine pancreas Diabetes. 63: 3428-3437. PMID 24848067 DOI: 10.2337/db13-1877  1
2014 Lopes PC, Fuhrmann A, Sereno J, Espinoza DO, Pereira MJ, Eriksson JW, Reis F, Carvalho E. Short and long term in vivo effects of Cyclosporine A and Sirolimus on genes and proteins involved in lipid metabolism in Wistar rats. Metabolism: Clinical and Experimental. 63: 702-15. PMID 24656168 DOI: 10.1016/j.metabol.2014.02.004  1
2014 Eriksson O, Selvaraju RK, Johansson L, Eriksson JW, Sundin A, Antoni G, Sörensen J, Eriksson B, Korsgren O. Quantitative imaging of serotonergic biosynthesis and degradation in the endocrine pancreas Journal of Nuclear Medicine. 55: 460-465. PMID 24525204 DOI: 10.2967/jnumed.113.125187  1
2013 Bengtsson SB, Eriksson J, Gärdenäs AI, Vinichuk M, Rosén K. Accumulation of wet-deposited radiocaesium and radiostrontium by spring oilseed rape (Brássica napus L.) and spring wheat (Tríticum aestívum L.). Environmental Pollution (Barking, Essex : 1987). 182: 335-42. PMID 23973885 DOI: 10.1016/j.envpol.2013.07.035  1
2013 Eriksson JC, Henriksson U. Thermodynamic properties of bridging clusters in thin films of water between hydrophobic surfaces assessed from surface force isotherms. Langmuir : the Acs Journal of Surfaces and Colloids. 29: 4789-95. PMID 23521404 DOI: 10.1021/la400446p  1
2013 Pereira MJ, Palming J, Rizell M, Aureliano M, Carvalho E, Svensson MK, Eriksson JW. The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue. Molecular and Cellular Endocrinology. 365: 260-9. PMID 23160140 DOI: 10.1016/j.mce.2012.10.030  1
2012 Hernestål-Boman J, Norberg M, Jansson JH, Eliasson M, Eriksson JW, Lindahl B, Johansson L. Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study. Cardiovascular Diabetology. 11: 152. PMID 23249721 DOI: 10.1186/1475-2840-11-152  1
2012 Barlind JG, Bauer UA, Birch AM, Birtles S, Buckett LK, Butlin RJ, Davies RD, Eriksson JW, Hammond CD, Hovland R, Johannesson P, Johansson MJ, Kemmitt PD, Lindmark BT, Morentin Gutierrez P, et al. Design and optimization of pyrazinecarboxamide-based inhibitors of diacylglycerol acyltransferase 1 (DGAT1) leading to a clinical candidate dimethylpyrazinecarboxamide phenylcyclohexylacetic acid (AZD7687). Journal of Medicinal Chemistry. 55: 10610-29. PMID 23116186 DOI: 10.1021/jm301296t  1
2012 Wang J, Li Z, Yoon RH, Eriksson JC. Surface forces in thin liquid films of n-alcohols and of water-ethanol mixtures confined between hydrophobic surfaces. Journal of Colloid and Interface Science. 379: 114-20. PMID 22608145 DOI: 10.1016/J.Jcis.2012.04.032  1
2012 Lindskog C, Korsgren O, Pontén F, Eriksson JW, Johansson L, Danielsson A. Novel pancreatic beta cell-specific proteins: antibody-based proteomics for identification of new biomarker candidates. Journal of Proteomics. 75: 2611-20. PMID 22465717 DOI: 10.1016/j.jprot.2012.03.008  1
2012 Torffvit O, Kalani M, Apelqvist J, Eliasson B, Eriksson JW, Brismar K, Jörneskog G. Increased Urine IgM and IgG(2) Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes. Biochemistry Research International. 2012: 480529. PMID 22400116 DOI: 10.1155/2012/480529  1
2012 Pereira MJ, Palming J, Rizell M, Aureliano M, Carvalho E, Svensson MK, Eriksson JW. mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes. Molecular and Cellular Endocrinology. 355: 96-105. PMID 22333157 DOI: 10.1016/j.mce.2012.01.024  1
2012 Ruge T, Sukonina V, Kroupa O, Makoveichuk E, Lundgren M, Svensson MK, Olivecrona G, Eriksson JW. Effects of hyperinsulinemia on lipoprotein lipase, angiopoietin-like protein 4, and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in subjects with and without type 2 diabetes mellitus. Metabolism: Clinical and Experimental. 61: 652-60. PMID 22078753 DOI: 10.1016/j.metabol.2011.09.014  1
2011 Wang J, Yoon RH, Eriksson JC. Excess thermodynamic properties of thin water films confined between hydrophobized gold surfaces. Journal of Colloid and Interface Science. 364: 257-63. PMID 21903219 DOI: 10.1016/J.Jcis.2011.08.027  1
2011 Liu L, Yu S, Khan RS, Ables GP, Bharadwaj KG, Hu Y, Huggins LA, Eriksson JW, Buckett LK, Turnbull AV, Ginsberg HN, Blaner WS, Huang LS, Goldberg IJ. DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle. Journal of Lipid Research. 52: 732-44. PMID 21205704 DOI: 10.1194/jlr.M011395  1
2011 Eriksson J, Fenyö D. Modeling mass spectrometry-based protein analysis. Methods in Molecular Biology (Clifton, N.J.). 694: 109-17. PMID 21082431 DOI: 10.1007/978-1-60761-977-2_8  1
2011 Jensen J, Ruge T, Lai YC, Svensson MK, Eriksson JW. Effects of adrenaline on whole-body glucose metabolism and insulin-mediated regulation of glycogen synthase and PKB phosphorylation in human skeletal muscle. Metabolism: Clinical and Experimental. 60: 215-26. PMID 20153492 DOI: 10.1016/j.metabol.2009.12.028  1
2010 Eriksson J, Fenyö D. Modeling experimental design for proteomics. Methods in Molecular Biology (Clifton, N.J.). 673: 223-30. PMID 20835802 DOI: 10.1007/978-1-60761-842-3_14  1
2010 Zhang G, Ueberheide BM, Waldemarson S, Myung S, Molloy K, Eriksson J, Chait BT, Neubert TA, Fenyö D. Protein quantitation using mass spectrometry. Methods in Molecular Biology (Clifton, N.J.). 673: 211-22. PMID 20835801 DOI: 10.1007/978-1-60761-842-3_13  1
2010 Fenyö D, Eriksson J, Beavis R. Mass spectrometric protein identification using the global proteome machine. Methods in Molecular Biology (Clifton, N.J.). 673: 189-202. PMID 20835799 DOI: 10.1007/978-1-60761-842-3_11  1
2009 Pereira MJ, Carvalho E, Eriksson JW, Crans DC, Aureliano M. Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes. Journal of Inorganic Biochemistry. 103: 1687-92. PMID 19850351 DOI: 10.1016/J.Jinorgbio.2009.09.015  1
2009 Sjöholm K, Lundgren M, Olsson M, Eriksson JW. Association of serum amyloid A levels with adipocyte size and serum levels of adipokines: differences between men and women. Cytokine. 48: 260-6. PMID 19758820 DOI: 10.1016/j.cyto.2009.08.005  1
2009 Ruge T, Lockton JA, Renstrom F, Lystig T, Sukonina V, Svensson MK, Eriksson JW. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index. Metabolism: Clinical and Experimental. 58: 860-6. PMID 19375766 DOI: 10.1016/j.metabol.2009.02.010  1
2009 Newcomer JW, Ratner RE, Eriksson JW, Emsley R, Meulien D, Miller F, Leonova-Edlund J, Leong RW, Brecher M. A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone Journal of Clinical Psychiatry. 70: 487-499. PMID 19358783 DOI: 10.4088/JCP.08m04132  1
2009 Kirchmann H, Mattsson L, Eriksson J. Trace element concentration in wheat grain: results from the Swedish long-term soil fertility experiments and national monitoring program. Environmental Geochemistry and Health. 31: 561-71. PMID 19263225 DOI: 10.1007/s10653-009-9251-8  0.01
2009 Senstad AC, Surén P, Brauteset L, Eriksson JR, Høiby EA, Wathne KO. Community-acquired pneumonia (CAP) in children in Oslo, Norway. Acta Paediatrica (Oslo, Norway : 1992). 98: 332-6. PMID 19006533 DOI: 10.1111/j.1651-2227.2008.01088.x  1
2009 Sahli D, Eriksson JW, Boman K, Svensson MK. Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes. Thrombosis Research. 123: 701-6. PMID 18945481 DOI: 10.1016/j.thromres.2008.07.015  1
2009 Sjöstrand M, Eriksson JW. Neuroendocrine mechanisms in insulin resistance. Molecular and Cellular Endocrinology. 297: 104-11. PMID 18599191 DOI: 10.1016/j.mce.2008.05.010  0.01
2008 Eriksson JW, Jansson PA, Carlberg B, Hägg A, Kurland L, Svensson MK, Ahlström H, Ström C, Lönn L, Ojbrandt K, Johansson L, Lind L. Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study. Hypertension (Dallas, Tex. : 1979). 52: 1030-7. PMID 18981327 DOI: 10.1161/HYPERTENSIONAHA.108.119404  1
2008 Sjöholm A, Agardh CD, Brismar K, Efendic S, Eliasson B, Eriksson JW, Frid A, Groop L, Holmgren J, Ridderstråle M, Smith U. [Reply on new drugs against type 2 diabetes: important to gain experience and knowledge]. Lakartidningen. 105: 1310, 1312. PMID 18561535  1
2008 Svensson MK, Eriksson JW. [Toe blood pressure measurement better than ankle blood pressure measurement in patients with diabetes]. Lakartidningen. 105: 925-6. PMID 18461865  1
2008 Möllsten A, Kockum I, Svensson M, Rudberg S, Ugarph-Morawski A, Brismar K, Eriksson JW, Dahlquist G. The effect of polymorphisms in the renin-angiotensin-aldosterone system on diabetic nephropathy risk. Journal of Diabetes and Its Complications. 22: 377-83. PMID 18413189 DOI: 10.1016/j.jdiacomp.2007.06.005  1
2008 Surén P, Try K, Eriksson J, Khoshnewiszadeh B, Wathne KO. Radiographic follow-up of community-acquired pneumonia in children. Acta Paediatrica (Oslo, Norway : 1992). 97: 46-50. PMID 18076723 DOI: 10.1111/j.1651-2227.2007.00567.x  1
2008 Krachler B, Norberg M, Eriksson JW, Hallmans G, Johansson I, Vessby B, Weinehall L, Lindahl B. Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus. Nutrition, Metabolism, and Cardiovascular Diseases : Nmcd. 18: 503-10. PMID 18042359 DOI: 10.1016/j.numecd.2007.04.005  1
2007 Eriksson JC, Henriksson U. Bridging-cluster model for hydrophobic attraction. Langmuir : the Acs Journal of Surfaces and Colloids. 23: 10026-33. PMID 17760469 DOI: 10.1021/la701331z  1
2007 Shin JH, Janer M, McNeney B, Blay S, Deutsch K, Sanjeevi CB, Kockum I, Lernmark A, Graham J, Arnqvist H, Björck E, Eriksson J, Nyström L, et al. IA-2 autoantibodies in incident type I diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5. Genes and Immunity. 8: 503-12. PMID 17641683 DOI: 10.1038/Sj.Gene.6364413  1
2007 Norberg M, Stenlund H, Lindahl B, Andersson C, Weinehall L, Hallmans G, Eriksson JW. Components of metabolic syndrome predicting diabetes: no role of inflammation or dyslipidemia. Obesity (Silver Spring, Md.). 15: 1875-85. PMID 17636107 DOI: 10.1038/oby.2007.222  1
2007 Eriksson JW. Metabolic stress in insulin's target cells leads to ROS accumulation - a hypothetical common pathway causing insulin resistance. Febs Letters. 581: 3734-42. PMID 17628546 DOI: 10.1016/j.febslet.2007.06.044  0.01
2007 Torffvit O, Eriksson JW, Henricsson M, Sundkvist G, Arnqvist HJ, Blohmé G, Bolinder J, Nyström L, Ostman J, Svensson M. Early changes in glomerular size selectivity in young adults with type 1 diabetes and retinopathy. Results from the Diabetes Incidence Study in Sweden. Journal of Diabetes and Its Complications. 21: 246-51. PMID 17616355 DOI: 10.1016/j.jdiacomp.2006.01.002  1
2007 Eriksson J, Fenyö D. Improving the success rate of proteome analysis by modeling protein-abundance distributions and experimental designs. Nature Biotechnology. 25: 651-5. PMID 17557102 DOI: 10.1038/nbt1315  1
2007 Kalani M, Silveira A, Blombäck M, Apelqvist J, Eliasson B, Eriksson JW, Fagrell B, Torffvit O, Hamsten A, Jörneskog G. Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers. Thrombosis Research. 120: 653-61. PMID 17275886 DOI: 10.1016/j.thromres.2006.12.006  1
2007 Farré-Castany MA, Schwaller B, Gregory P, Barski J, Mariethoz C, Eriksson JL, Tetko IV, Wolfer D, Celio MR, Schmutz I, Albrecht U, Villa AE. Differences in locomotor behavior revealed in mice deficient for the calcium-binding proteins parvalbumin, calbindin D-28k or both. Behavioural Brain Research. 178: 250-61. PMID 17275105 DOI: 10.1016/J.Bbr.2007.01.002  1
2007 Renström F, Burén J, Svensson M, Eriksson JW. Insulin resistance induced by high glucose and high insulin precedes insulin receptor substrate 1 protein depletion in human adipocytes. Metabolism: Clinical and Experimental. 56: 190-8. PMID 17224332 DOI: 10.1016/j.metabol.2006.09.012  1
2006 Eriksson JL, Villa AEP. Learning of auditory equivalence classes for vowels by rats Behavioural Processes. 73: 348-359. PMID 16997507 DOI: 10.1016/J.Beproc.2006.08.005  1
2006 Kizling J, Kronberg B, Eriksson JC. On the formation and stability of high internal phase O/W emulsions. Advances in Colloid and Interface Science. 123: 295-302. PMID 16857157 DOI: 10.1016/j.cis.2006.05.006  0.01
2006 Svensson M, Eriksson JW. Insulin resistance in diabetic nephropathy--cause or consequence? Diabetes/Metabolism Research and Reviews. 22: 401-10. PMID 16703644 DOI: 10.1002/dmrr.648  1
2006 Ossipova E, Fenyö D, Eriksson J. Optimizing search conditions for the mass fingerprint-based identification of proteins. Proteomics. 6: 2079-85. PMID 16485258 DOI: 10.1002/pmic.200500484  1
2005 Olsson IM, Eriksson J, Oborn I, Skerfving S, Oskarsson A. Cadmium in food production systems: a health risk for sensitive population groups. Ambio. 34: 344-51. PMID 16092267  0.01
2005 Burén J, Eriksson JW. Is insulin resistance caused by defects in insulin's target cells or by a stressed mind? Diabetes/Metabolism Research and Reviews. 21: 487-94. PMID 15977304 DOI: 10.1002/dmrr.567  1
2005 Lindmark S, Lönn L, Wiklund U, Tufvesson M, Olsson T, Eriksson JW. Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance. Obesity Research. 13: 717-28. PMID 15897481 DOI: 10.1038/oby.2005.81  1
2005 Sahli D, Svensson M, Lidgren J, Ojbrandt K, Eriksson JW. Evaluation of simple non-invasive techniques for assessment of lower extremity arterial disease. Clinical Physiology and Functional Imaging. 25: 129-34. PMID 15888091 DOI: 10.1111/j.1475-097X.2005.00597.x  1
2005 Renström F, Burén J, Eriksson JW. Insulin receptor substrates-1 and -2 are both depleted but via different mechanisms after down-regulation of glucose transport in rat adipocytes. Endocrinology. 146: 3044-51. PMID 15845625 DOI: 10.1210/en.2004-1675  1
2005 Eriksson J, Fenyö D. Protein identification in complex mixtures. Journal of Proteome Research. 4: 387-93. PMID 15822914 DOI: 10.1021/pr049816f  1
2005 Bresell A, Weinander R, Lundqvist G, Raza H, Shimoji M, Sun TH, Balk L, Wiklund R, Eriksson J, Jansson C, Persson B, Jakobsson PJ, Morgenstern R. Bioinformatic and enzymatic characterization of the MAPEG superfamily. The Febs Journal. 272: 1688-703. PMID 15794756 DOI: 10.1111/j.1742-4658.2005.04596.x  0.01
2005 Eriksson J, Villa AE. Event-related potentials in an auditory oddball situation in the rat. Bio Systems. 79: 207-12. PMID 15649606 DOI: 10.1016/J.Biosystems.2004.09.017  1
2005 Iglesias J, Eriksson J, Grize F, Tomassini M, Villa AE. Dynamics of pruning in simulated large-scale spiking neural networks. Bio Systems. 79: 11-20. PMID 15649585 DOI: 10.1016/J.Biosystems.2004.09.016  1
2005 Kumpulainen AJ, Persson CM, Eriksson JC, Tyrode EC, Johnson CM. Soluble monolayers of n-decyl glucopyranoside and n-decyl maltopyranoside. Phase changes in the gaseous to the liquid-expanded range. Langmuir : the Acs Journal of Surfaces and Colloids. 21: 305-15. PMID 15620319 DOI: 10.1021/la047791t  1
2005 Tulinius M, Darin N, Wiklund LM, Holmberg E, Eriksson JE, Lissens W, De Meirleir L, Holme E. A family with pyruvate dehydrogenase complex deficiency due to a novel C>T substitution at nucleotide position 407 in exon 4 of the X-linked Epsilon1alpha gene. European Journal of Pediatrics. 164: 99-103. PMID 15558317 DOI: 10.1007/s00431-004-1570-2  0.01
2005 Iglesias J, Eriksson J, Pardo B, Tomassini M, Villa AEP. Stimulus-driven unsupervised synaptic pruning in large neural networks Lecture Notes in Computer Science. 59-68. DOI: 10.1007/11565123_6  1
2004 Kumpulainen AJ, Persson CM, Eriksson JC. Headgroup and hydrocarbon tail effects on the surface tension of sugar-based surfactant solutions. Langmuir : the Acs Journal of Surfaces and Colloids. 20: 10935-42. PMID 15568843 DOI: 10.1021/la048815z  1
2004 Sahli D, Eliasson B, Svensson M, Blohmé G, Eliasson M, Samuelsson P, Ojbrandt K, Eriksson JW. Assessment of toe blood pressure is an effective screening method to identify diabetes patients with lower extremity arterial disease. Angiology. 55: 641-51. PMID 15547650  1
2004 Kumpulainen AJ, Persson CM, Eriksson JC. n-Decyl-glucopyranoside and n-decyl-maltopyranoside gibbs monolayers. Phase changes in the dilute liquid-expanded range. Langmuir : the Acs Journal of Surfaces and Colloids. 20: 10534-41. PMID 15544382 DOI: 10.1021/la0488497  1
2004 Eriksson JW. [Exciting findings can change the view on the pathogenesis of type 2 diabetes. Impaired mitochondrial function can explain metabolic disorders in several organs]. Lakartidningen. 101: 2992-3. PMID 15493637  0.01
2004 Eriksson J, Fenyö D. The statistical significance of protein identification results as a function of the number of protein sequences searched. Journal of Proteome Research. 3: 979-82. PMID 15473685 DOI: 10.1021/pr0499343  1
2004 Ossipova E, Nord LI, Kenne L, Eriksson J. Method for differential detection and identification of components in protein mixtures analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry : Rcm. 18: 2053-8. PMID 15378717 DOI: 10.1002/rcm.1583  1
2004 Torres O, Eriksson J, Moreno JM, Villa A. Hardware optimization and serial implementation of a novel spiking neuron model for the POEtic tissue. Bio Systems. 76: 201-8. PMID 15351143 DOI: 10.1016/J.Biosystems.2004.05.012  0.01
2004 Weber P, Eriksson J, Seewer S. Medical activities and statistics. Medicinski Arhiv. 58: 86-7. PMID 15137212  0.01
2004 Svensson M, Eriksson JW, Dahlquist G. Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden. Diabetes Care. 27: 955-62. PMID 15047655  1
2004 Eriksson J, Fenyö D. Probity: a protein identification algorithm with accurate assignment of the statistical significance of the results. Journal of Proteome Research. 3: 32-6. PMID 14998160  1
2003 Persson CM, Jonsson AP, Bergström M, Eriksson JC. Testing the Gouy-Chapman theory by means of surface tension measurements for SDS-NaCl-H2O mixtures. Journal of Colloid and Interface Science. 267: 151-4. PMID 14554179  1
2003 Svensson M, Sundkvist G, Arnqvist HJ, Björk E, Blohmé G, Bolinder J, Henricsson M, Nyström L, Torffvit O, Waernbaum I, Ostman J, Eriksson JW. Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care. 26: 2903-9. PMID 14514599  1
2003 Kalani M, Apelqvist J, Blombäck M, Brismar K, Eliasson B, Eriksson JW, Fagrell B, Hamsten A, Torffvit O, Jörneskog G. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study. Diabetes Care. 26: 2575-80. PMID 12941721  1
2003 Burén J, Lindmark S, Renström F, Eriksson JW. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo? Metabolism: Clinical and Experimental. 52: 239-45. PMID 12601640 DOI: 10.1053/meta.2003.50041  1
2003 Henricsson M, Nyström L, Blohmé G, Ostman J, Kullberg C, Svensson M, Schölin A, Arnqvist HJ, Björk E, Bolinder J, Eriksson JW, Sundkvist G. The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care. 26: 349-54. PMID 12547861  1
2003 Eriksson JW, Burén J, Svensson M, Olivecrona T, Olivecrona G. Postprandial regulation of blood lipids and adipose tissue lipoprotein lipase in type 2 diabetes patients and healthy control subjects. Atherosclerosis. 166: 359-67. PMID 12535750  1
2003 Burén J, Liu HX, Lauritz J, Eriksson JW. High glucose and insulin in combination cause insulin receptor substrate-1 and -2 depletion and protein kinase B desensitisation in primary cultured rat adipocytes: possible implications for insulin resistance in type 2 diabetes. European Journal of Endocrinology. 148: 157-67. PMID 12534369  1
2002 Ahrén B, Simonsson E, Larsson H, Landin-Olsson M, Torgeirsson H, Jansson PA, Sandqvist M, Båvenholm P, Efendic S, Eriksson JW, Dickinson S, Holmes D. Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes. Diabetes Care. 25: 869-75. PMID 11978683  1
2002 Eriksson J, Fenyö D. A model of random mass-matching and its use for automated significance testing in mass spectrometric proteome analysis. Proteomics. 2: 262-70. PMID 11921442 DOI: 10.1002/1615-9861(200203)2:3<262::AID-PROT262>3.0.CO;2-W  1
2002 Burén J, Liu HX, Jensen J, Eriksson JW. Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes. European Journal of Endocrinology. 146: 419-29. PMID 11888850  1
1999 Villa AE, Eriksson J, Eriksson C, Haeberli C, Hyland B, Najem A. Stimulus congruence affects perceptual processes in a novel Go/Nogo conflict paradigm in rats. Behavioural Processes. 48: 69-88. PMID 24897564 DOI: 10.1016/S0376-6357(99)00070-4  1
1997 Eriksson JW, Lo Nnroth P, Wesslau C, Smith U. Insulin Promotes and Cyclic Adenosine 3',5'-Monophosphate Impairs Functional Insertion of Insulin Receptors in the Plasma Membrane of Rat Adipocytes: Evidence for Opposing Effects of Tyrosine and Serine/Threonine Phosphorylation. Endocrinology. 138: 607-616. PMID 28199521 DOI: 10.1210/endo.138.2.4948  0.01
Show low-probability matches.